Fifth Third Bancorp
TXG icon

Fifth Third Bancorp’s 10x Genomics TXG Stock Holding History

Fifth Third Bancorp’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.6K Sell
2,286
-87
-4% -$2.28K ﹤0.01% 3002
2026
Q1 		$50.4K Buy
+2,373
New +$47.4K ﹤0.01% 3191
2025
Q2 		– Sell
-76
Closed -$663 – 2643
2025
Q1 		$663 Buy
+76
New +$958 ﹤0.01% 2429
2024
Q4 		– Sell
-5,679
Closed -$128K – 2612
2024
Q3 		$128K Sell
5,679
-30
-0.5% -$620 ﹤0.01% 1103
2024
Q2 		$111K Sell
5,709
-13
-0.2% -$340 ﹤0.01% 1110
2024
Q1 		$215K Buy
5,722
+5,475
+2,217% +$241K ﹤0.01% 954
2023
Q4 		$13.8K Buy
247
+9
+4% +$392 ﹤0.01% 1882
2023
Q3 		$9.82K Hold
238
– – ﹤0.01% 1959
2023
Q2 		$13.3K Hold
238
– – ﹤0.01% 1894
2023
Q1 		$13.3K Hold
238
– – ﹤0.01% 1987
2022
Q4 		$8.67K Hold
238
– – ﹤0.01% 2019
2022
Q3 		$7K Hold
238
– – ﹤0.01% 2088
2022
Q2 		$11K Hold
238
– – ﹤0.01% 1975
2022
Q1 		$18K Sell
238
-300
-56% -$26.2K ﹤0.01% 1867
2021
Q4 		$80K Buy
538
+500
+1,316% +$76.6K ﹤0.01% 1314
2021
Q3 		$6K Hold
38
– – ﹤0.01% 2174
2021
Q2 		$7K Sell
38
-44
-54% -$7.96K ﹤0.01% 2138
2021
Q1 		$15K Buy
82
+44
+116% +$7.6K ﹤0.01% 1888
2020
Q4 		$5K Sell
38
-3,789
-99% -$550K ﹤0.01% 2119
2020
Q3 		$477K Hold
3,827
– – ﹤0.01% 639
2020
Q2 		$342K Buy
3,827
+3,789
+9,971% +$295K ﹤0.01% 713
2020
Q1 		$2K Hold
38
– – ﹤0.01% 1996
2019
Q4 		$3K Buy
+38
New +$2.29K ﹤0.01% 2031

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fifth Third Bancorp's TXG Position: Q2 2026 in Review

Fifth Third Bancorp reduced its 10x Genomics (TXG) stake by 3.7% in Q2 2026, selling an estimated $2.28K and leaving 2,286 shares worth $87.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

Fifth Third Bancorp first reported a position in TXG in Q4 2019 and has held it in 23 quarters since. The position peaked at $477K in Q3 2020. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Fifth Third Bancorp held 2,286 shares of 10x Genomics worth $87.6K as of Q2 2026.
  • Fifth Third Bancorp sold 87 10x Genomics shares in Q2 2026, an estimated $2.28K.
  • 10x Genomics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3002 holding.
  • Fifth Third Bancorp first reported a position in 10x Genomics in Q4 2019 and has held it in 23 quarters since.
  • Fifth Third Bancorp's 10x Genomics position peaked at $477K in Q3 2020.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.